thr patient Flashcards

1
Q

give a feature of steroid hormones

A

lipophillic

Lipophillic; can readily enter into the cell. Usually transported
in plasma via carrier proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a ligand

A

Ligands are molecules that bind to receptors, enzymes, or other molecular targets, often with high specificity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ligands for nuclear receptors

A

Glucocorticoids,mineralocorticoids, sex hormones
Thyroid hormones
Retinoic acid
Endogenous lipids (act on the PPARs)
Foreign chemicals (act on PXRs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is a nuclear receptor

A

A nuclear receptor is a class of proteins found within cells that are responsible for sensing and responding to various molecules, including hormones, vitamins, and other signaling molecules. These receptors play a crucial role in regulating gene expression and controlling numerous physiological processes such as metabolism, development, and reproduction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is chromosome puffing

A

blood fly salivary gland - large chromosomes - identify in light microscope

when you add a steroid / insect hormone, there was swelling in certain regions in the chromosome. PUFFING

+ steroid
+ inhibitor of mRNA
synthesis - add both you got rid of the swelling / puffing

steroids work increasing MRNA synthesis, interact with DNA of chromosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe the structure of a nuclear receptor

A

N-C
N
A/B - variable region
C - DNA binding zinc fingers
D - hinge region
E/F ligand binding
C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what two domains do receptors have

A

hormone binding domain
DNA binding domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what does a mineralcorticoid do

A

Binds Aldosterone
Produces transport proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does a glucocorticoid do

A

Binds cortisol
Inhibits COX-2 production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is a chimeric receptor

A

Binds aldosterone
Inhibits COX2 production

BUT
has a hormone binding domain from mineral corticoid and DNA bindin domain from glucocorticoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe hormone binding to receptor

A

hormone bypassed cemm membrane as its lipophillic

proteins are bound to receptor and hold it in an inactive form

when hormone binds protiens fall off

receptor usually usually moves into nucleus

binds to dimer

mrna synthesis

binding of DNA to a monomer usually inhibits mrna

tethering when receptor binds to TF -m inhibition of mrna

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are type 2 nuclear receptors

A

Not associated with heat shock proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is a heat shock protein

A

Heat shock proteins (HSPs), also known as stress proteins, are a diverse group of proteins found in virtually all living organisms. They are synthesized in response to various stressors, including heat shock, oxidative stress, exposure to toxins, infection, and other cellular insults. Heat shock proteins play crucial roles in maintaining cellular homeostasis, protecting cells from damage, and facilitating cellular recovery under stressful conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are zinc fingers

A

Zinc fingers are small protein structural motifs that can bind to specific sequences of DNA or RNA. They are characterized by the coordination of one or more zinc ions in a finger-like structure, which stabilizes the protein’s fold and allows it to interact with nucleic acids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

tell me about dna binding sites and inverted repeats

A

Some response elements lack the repeat (eg GATC rather than GATCCTAG).
In this case only a single receptor binds. For glucocorticoids, this receptor then
binds a protein that makes it harder for RNA polymerase to bind, causing
inhibition of RNA synthesis

ensure receptors bind as dimers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drugs acting on nuclear receptors

A

Anti-inflammatory agents
Clofibrate PPARa (cholesterol lowering)
Thiazolidines PPARg (type II diabetes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

where else can some steroids also act

A

Some steroids can also act via membrane bound receptors to produce very rapid responses
Steroid transport proteins exist to facilitate steroid entry into cells and may be important in signalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe transcription

A

steroid receptor hormone binds (usually dimer)

Dna unwinds from chromosome

steroid receptor dimer and RNA polymerase get close together and make contact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Stages of development and timing of exposure P&B

A

Potential harm influenced by timing of exposure
– < 17 days = Pre-embryonic period (All or nothing)
– 18-56 days = Embryonic period (Organ development)
– Weeks 8 – 38/40 = fetal stage (Growth)
* Different defects occur with drugs in different
periods of pregnancy (Phenobarbital)
* Time period crucial
– Spina Bifida (Valproate, Carbamazepine)
– Cleft Palate (Methotrexate, Valproate)
– Pulmonary Hypertension PPHN (NSAID’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Teratogenicity what is teratogen

A

Teratogen is an agent that interferes with the normal
growth and development of the fetus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

effects of teratogen

A

Potential effects include
– Chromosomal abnormalities
– Structural malformations
– Inter Uterine Growth Retardation
– Fetal death
– Behavioural or intellectual abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

incidents of teratogen

A

2-3% Incidence of spontaneous malformations in newborn
babies in Europe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pharmacokinetic changes P&B

A

Volume of distribution
– ⇑body water and fat
– ⇑cardiac output
* Protein Binding
– ⇓albumin
* Clearance
– ⇑GFR by 50% in first weeks of pregnancy
* = Need for Increased monitoring in some drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Sodium Valproate P&B

A

Pregnancy Prevention Programme
* Smaller pack sizes to ensure original box given
with warnings
* Annual acknowledgement of Risk Form - specialist
* Patient alert card issued with every prescription
* Contraception – considerations and compliance
* Regular pregnancy tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

role of placenta

A

nutrient uptake,
waste elimination & gas
exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what medicines cross placenta quicker as the placenta is not a barrier

A

Lipid soluble, unionised
medicines cross placenta
quicker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Principle of medicine use

A

Medicines should only be prescribed
when BENEFITS to the mother >
RISK to the fetus
* Simple Rules:
Preferably use agents extensively used before
Use lowest effective dose
* To aid compliance all risks and benefits should be discussed
with mothers for each medication and their importance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

prescribing in pregnancy things to consider

A

Trimester/
number of
weeks?
Past pregnancies?
Previous
exposure?
Necessity for
therapy?
Duration of
therapy
Drug
properties i.e
half life,
Teratogenicity
risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Nutrition in pregnancy

A

Folic acid supplementation
– Essential vitamin to ensure neural tube closure
– Low risk; 400microgram OD pre conception to week12
– High risk; 5mg OD before conception to week12
* Vitamin D (10mcg per day)
* No Alcohol government advice
* Vitamin A (restrict to 700mcg)
* Vitamin K supplementation
– May be required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Medication use effect to the fetus depends upon
many factors

A

Timing of exposure
– Dose
– Maternal Disease
– Genetic Susceptibility
* Teratogenicity can be dose dependent.
* Can get incidence of spontaneous malformations in
normal population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

National Recommendations on Breastfeeding
World Health Organisation (WHO)

A

Initiate breastfeeding within 1st hour of life and
continue exclusively for first 6 months of life
* Breast fed “on demand” – eg led by the baby, not
at specific times
* No bottles or dummys should be used to avoid
latching on issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Advantages of Breastfeeding child

A

Contains secretory IgA (sustained benefit if BF >13wk)
* Child (seen if BF >13weeks)
– Reduces risk of infection
* GI (diarrhoea), UTI, otitis media, LRTI, NEC
– Increased cognitive development
– Protection against development of atopic-disease
– Reduction in childhood leukaemia’s
– Reduction in hypertension, diabetes and obesity

33
Q

advantages of breastfeeding for the mother

A

Reduction in risk of pre-menopausal breast cancer, ovarian cancer
and hip fractures.

34
Q

Potential Barriers for Breastfeeding

A

Not enough breast milk
– Sore/cracked nipples
– Breast engorgement
– Blocked duct / mastitis
– Latching problems
– Painful, messy and tiring
– Difficult to establish
– Breast fed babies wake more often during the night
– More difficult for mothers to return to work
– Mother may need to modify her diet
– Privacy/ public perceptions

35
Q

Breast milk vs Formula milk

A

Formula milk not a true replica
* Breast milk complex, contains antibodies, enzymes and
hormones.
* Colostrum (yellow milk) high in immunoglobulin’s
* Newborn infants have high calorific and fluid requirements
– Av fluid 150ml/kg/day
– Calories 110kcal/kg/day
* 40% of energy comes from carbohydrate (mainly lactose) and
50% from fat.

36
Q

Prescribing: Pharmacokinetic considerations P&B

A

Oral bioavailability eg LMWH’s, insulin
* Plasma Protein Binding eg ibuprofen
* Milk:Plasma ratios – lower the value the smaller the
transfer eg sertraline = 0.89, iodine = 26
* MW - >MW have lower oral bioavailability
* 1st pass metabolism eg morphine
* Relative infant dose – Less than 10%
* Half life – affect infants excretion

37
Q

prescribing considerations P&B

A

Other factors
– Age of baby – drug clearance
– Volume of feeds
– Frequency of feeds
* Generally manufacturers do not gain a licence for
drugs in breastfeeding so are cautious and
recommend against it.
* Due to ethics there are no large randomised studies
on drugs in breast feeding.

38
Q

Classification of drug use in breast feeding

A

Drug used with caution or
contraindicated
* Safe as present in milk in
amounts too small to be
harmful to infant
* Safe as present in milk in
significant amounts but not
known to be harmful.

39
Q

Medicines considered UNSAFE in breast feeding

A

Medicines considered UNSAFE in breast feeding
◦ Indomethacin
◦ Clindamycin
◦ Mesalazine
◦ Amiodarone
◦ Tetracyclines (long-term)
◦ Statins
◦ Codeine/Morphine

40
Q

Medicines use with CAUTION in breast feeding

A

Atenolol
 Diuretics
➔ Case report of bradycardia,
cyanosis and hypothermia
➔May suppress lactation = diuretics

41
Q

Medicines SAFE in breastfeeding

A

Penicillins
 Erythromycin
 Cefalexin
 Ibuprofen
 Diclofenac
 Senna
 Lactulose
 Loperamide

42
Q

Medicines affecting lactation

A

Oestrogens have a significant effect on suppressing milk
production
– Can use POP
* Dopamine receptor
agonists: suppress
lactation
* Dopamine antagonist:
Promote lactation

43
Q

General Principles for drug treatment in breastfeeding and pregnancy

A

If not necessary avoid drug use
– Limit OTC product use
* Avoid known toxic drugs
* Generally if drug is licensed in infant it may be ok
* Neonates at greatest risk
* Monitor infants for side effects
* Avoid long acting formulations
* Avoid new medicines
– Limited data
* Most important is Benefit/Risk ratio

44
Q

A mother is breastfeeding a 5 week old full term
healthy infant.
* She usually uses Loratadine when she has hayfever.
* Can she use Loratadine and breastfeed safely?

A

SPC Clarityn available at eMC
– “Loratadine is excreted in breast milk.
Therefore, the use of Clarityn Allergy Tablets
is not recommended in breast-feeding
women.”
* BNF
– “Most antihistamines are present in breast
milk in varying amounts; although not known
to be harmful, most manufacturers advise
avoiding their use in mothers who are breast-
feeding.”

decicion from other sources: The amount excreted in to milk is low.
* No harm has been reported from use during
breastfeeding.
* Considered to be compatible.

45
Q

Conclusions P&B

A

Important to understand principles of prescribing in pregnancy
and breast feeding
* Ultimately
 Understand stages of pregnancy and how it affects drug
therapy
 Know the benefits of breastfeeding
◦ Awareness on organisations and government message
◦ How breastfeeding affects drug therapy choice
 Overall be able to apply knowledge and use appropriate
references to specific patients and make evidence based
decisions on drug therapy in pregnancy and lactation

46
Q

0-27 days old

A

neonate

47
Q

28 days - 23 months

A

infant / toddler

48
Q

2-11 years

A

child

49
Q

12-16/18

A

adolescent

50
Q

first 18 months movement

A

Movement
– 0-3mths: Lift head.
– 6-8mths: Sit.
– 10-18mths: Walk unaided (mostly)

51
Q

first 18 months hearing and talking

A

6mths: Cooing(baby noises).
-12mths: First words.

52
Q

first 18 months sight

A

2wks: Recognise parents by sight.
– 6mths: Able to see fully.

53
Q

onsiderations of medicines in children

A

They are NOT small adults
* Large varied population.
* Significant pharmacokinetic (ADME) and pharmacodynamic differences
between child age bands and with adults.

54
Q

Pharmacokinetic differences
Absorption (orally) children

A

Gastrointestinal tract changes
* Neonates ⇑pH (6-8)
– ⇓ bioavailability of acidic medicines (phenobarbital,
phenytoin).
– ⇑ bioavailability of weakly basic drugs (penicillin,
erythromycin).
* Gastric emptying and intestinal motility decreased in
neonates
– Normal intestinal function by 4-6mths.
– Normal gastric emptying and pH by 3yrs.

55
Q

Pharmacokinetic differences for children

A

Routes of administration:
* I.M. Injection:
– Painful and distressing for children.
– Rate and extent of absorption depends upon blood
flow to the muscle.
* Rectal:
– May be slow and unpredictable.
– Useful if vomiting or NBM.

Neonatal liver is immature.
* Can’t metabolise drugs as efficiently:
E.g. explains “gray baby syndrome with chloramphenicol
* Renal clearance can take 8-12 months to develop to adult values
* Can result in half lives and higher plasma concentrations of hepatic and
renally excreted drugs:
Phenytoin, Analgesics, Cardiac glycosides
* Useful for phenobarbitone- only needs 1 loading dose as remains in
circulation for longer.
* However, vancomycin and gentamicin have narrow therapeutic index-
reduced frequency of doses to avoid toxicity

56
Q

Absorption significantly greater than in adults due to

A
  1. Neonates have thinner stratum corneum.
  2. ⇑ Ratio of surface area : weight
57
Q

Intraosseous (IO)?

A

Injection into bone.
‒ Usually tibial injection.

58
Q

Intravenous Administration children

A

Guaranteed method of drug delivery.
* Preferable in neonatal period:
- Clinical condition
- Prematurity
- Gastric instability
* Caution with rates of infusion and fluid volumes as different
size to an adult:
‒ Term neonates should receive 60-150ml/kg/day of
fluid.
‒ Average 3 year old (15kg) can have 1250ml/day

59
Q

Volume of Distribution children

A

Water = high in the neonate
and slowly reduces to 60%
in children
Body Fat = low in
premature babies ~ 2%,
high in children up to 1yr
~30%, reduced back to
adult value ~18%

take into account water soluble drugs

60
Q

Protein Binding in children

A

Protein is altered in neonates
and young children; gets reduced
* Potentially more free drug available.
* Therefore; need to reduce doses of highly protein bound
drugs e.g. phenytoin, sodium valproate, furosemide.

61
Q

Pharmacodynamic Effects children

A

Talking about the interaction between drug and receptor.
* Less is known about this.
* May explain increased hepatic toxicity seen in infants on
sodium valproate

62
Q

differences in monitoring for children

A

Haematological changes
– Hb and neutrophil counts are lower in younger
children.
– Lymphocyte counts have a higher mean in younger
children.
– Platelets decreased in first few months, normalised by
6 months.
* NB labs have own standard values so important to use
these

BP
HR
respiratory canges

63
Q

Calculating drug doses children

A

Dose calculations based on:
‒ Weight
‒ Body Surface Area
 BSA
‒ Nomograms available
‒ BSA = √ (weight x height / 3600)
‒ Used mainly for chemotherapy and other medicines like
IV aciclovir.
 May need to use ideal body weight in obesity (better to underdose)

64
Q

Child friendly medicines

A

Most licensed oral medicines are tablets
Child friendly medicines
* Tablet crushing is
common.
* Don’t crush MR, LA or
cytotoxic preparations.
* Can disperse in water
and take fractions of
dose- careful as not all
meds are compatible.

Tablet cutting is also
common.
* Can split tablets.
* Caution with unscored
tablets.
* Should not split MR, EC
or cytotoxic meds.

65
Q

child friendly medication forms other than tablet

A

Suppositories:
‒ Uniformity of dose uncertain.
‒ Split lengthways- for comfort.
* Patches:
‒ Can cut matrix patches.
‒ Cannot cut reservoir patches
* Liquids:
‒ Formulations can contain E numbers,
ethanol, sweeteners, preservatives

66
Q

Licensing of medicines in paediatrics

A

All medicines must have a product license or marketing
authorisation.
* Many granted a license for adult use have NOT been
tested in children.
* Things have changed:
– EU paediatric regulation came into force 2007 to help:
>Improve health of children
>Facilitate development and availability of medicines for children
>Ensure medicines are high quality, ethically researched and
authorised appropriately
>Improve the availability of information on the use of medicines
– Manufacturers must provide paediatric information when applying for a
marketing authorisation (USA, Europe) known as PUMA

67
Q

Extent of Unlicensed medicine use

A

Unlicensed or off-label drugs are received by:
* 90% babies in neonatal ICU.
* 70% patients on PICU.
* 67% children in European hospitals.
* 11% children treated by GPs.

68
Q

what does unlicenced medicines mean

A

MHRA

Unlicensed medicines have no marketing authorisation
and are used when no appropriate licensed preparations
are suitable/available

69
Q

examples of unlicenced medicines for children

A

Extemporaneous dispensing:
‒ Crushing tablets or opening capsules.
 ‘Specials’:
‒ Use of a unlicensed product from a specials
manufacturer. E.g. Clonazepam suspension.
 Specialist import:
‒ Import licensed medicine from another country.
 ‘Named patient’ supply:
‒ Pharmaceutical companies supply for specific patient.

70
Q

Off-Label” Medicines

A

Off-Label” medicines have a marketing authorisation but
are used outside their product license

70
Q

off label examples

A

Lower or higher dose.
‒ Patient age.
‒ Indication.
‒ Route of administration.
‒ Contraindications.

71
Q

Licensing of medicines in paediatrics

A

Regarding the use of unlicensed and off label medicines
in paediatrics, the RCPCH and NPPG advise:
– Informed use of UL or OL medicines in paediatrics is
necessary.
– It is not necessary to obtain consent from
parents/patients to administer such medicines beyond
those steps taken for licensed medicines.

72
Q

Availability of medications
effect on pediactrics

A

Currently there are significant issues sourcing medications
in the UK.
* Not just in paediatrics, but adults too.
* Issues around common medicines and formulations used in
paediatrics.
* Reasons include:
* COVID and its aftermath
* Brexit
* Wars in Ukraine and other countries
* We have to use more UL/off label medications as a result.

73
Q

Errors in paediatrics

A

Children are more vulnerable to errors with
medication and have reduced reserve to
respond to incorrect dosing.
* More complex calculations.
* Suitability of formulations available.
* Different diseases.
* 10 and 100 fold dose errors are not uncommon.
* Variable weight.

74
Q

Preventing errors in paediatrics

A

Check & record allergies
and reaction.
 Confirm correct weight.
 Weight based dose should
 not exceed adult dose!
 Prescription must be legible.
 Each step of calculations should be
written out and double checked

75
Q

Where to look for doses in children

A

BNFC.
 National standard text.
 Monographs as per adult book.
 Info on use of a medicine in renal and liver impairment,
pregnancy or breast feeding within monograph
medicines complete

76
Q

Where to look for doses in children

A

Neonatal Formulary.
* Very comprehensive text for doses in neonates.
* Evelina (Guy’s and St Thomas’ paeds formulary)
* Available via app (available to all), or Clinibee- login
required. Use with caution as undergraduate
Medicines for Children.
* Preceded and predates BNFC
Lexi-Comp Pediatric Dosage
Handbook.
* Comprehensive text with detailed
drug monographs.
* American- FDA licensing, their
dosing regimes.
* Useful supplementary information
in appendices.

77
Q
A